Updated:
Neon Therapeutics, Inc.
Neon Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001694187, and its reported industry...
Overview
Neon Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001694187, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2020-03-02, it reported net income of USD -79,776,000; total assets of USD 46,372,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Neon Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001694187
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2019USD | -$79.8M | $46.4M | $29.4M | -$73.4M | |
| FY2018USD | -$76.9M | $114.1M | $52.7M | -$63.4M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| SC 13G | — | 13G | |
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| SC 13D | — | SC 13D | |
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Neon Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.